[HTML] mdpi.com

[HTML][HTML] Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI

G Liu, J Ling, L He, Y Xu, T Chen, C Shi, L Luo - Pharmaceutics, 2022 - mdpi.com
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI

G Liu, J Ling, L He, Y Xu, T Chen, C Shi, L Luo - Pharmaceutics, 2023 - ncbi.nlm.nih.gov
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …

Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI

G Liu, J Ling, L He, Y Xu, T Chen, C Shi… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …

Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI.

G Liu, J Ling, L He, Y Xu, T Chen, C Shi… - …, 2023 - search.ebscohost.com
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …

Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI

G Liu, J Ling, L He, Y Xu, T Chen, C Shi… - …, 2023 - search.proquest.com
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …

Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI.

G Liu, J Ling, L He, Y Xu, T Chen, C Shi, L Luo - Pharmaceutics, 2022 - europepmc.org
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer
therapy, while effective drug delivery remains a technical hurdle. A theranostic approach …